Gastro Care Partners’ Post

Revolutionizing Gastrointestinal Treatment: Exploring the Benefits and Procedures of Endoscopic Submucosal Dissection (ESD) #Gastroenterology #MedicalInnovation #Healthcare #Endoscopy #ESD #SRMGlobalHospitals #MinimallyInvasive #CancerTreatment #PatientCare https://lnkd.in/dF2Dz4Tk

My latest spotlight profile for GI & Hepatology News!

📃Scientific paper: Percutaneous nephroscopy combined with ultrasound-guided negative-pressure suction for the treatment of perinephric abscess: a case series Abstract: Background Drainage is indicated in many patients with a perinephric abscess (PA). Surgical drainage is associated with trauma and slow recovery, while percutaneous drainage can be ineffective in some patients. We report on 11 patients with PA treated by percutaneous nephroscopy combined with ultrasound-guided negative-pressure suction under local anesthesia. Methods This case series included 11 PA patients operated on from January 2013 to June 2020. All patients received percutaneous nephroscopy combined with ultrasound-guided negative-pressure suction. Data, including operation time, volume of intraoperative blood loss, volume of intraoperative pus suction, time of postoperative drainage tube indwelling, time to restore normal body temperature, length of postoperative hospital stay, and intraoperative and postoperative complications, were collected. Results The age of the patients was 59 (53–69) years. Eight, six, two, and two patients had hypertension, type 2 diabetes, rheumatoid arthritis, and renal calculi, respectively. The operations were successful forall11 patients. Eight, two, and one patients required one, two, and three channels, respectively, to clear their abscess. The average operation time was 44 (30–65) min, and intraoperative blood loss was 16 (10–20) ml. The volume of intraoperative pus suction was 280 (200–400) ml, time of postoperative drainage tube indwelling was 8.2 (6–12) days, and time to restoring normal body temperature was 0.8 (0.5–2) ... Continued on ES/IODE ➡️ https://etcse.fr/dPbDu ------- If you find this interesting, feel free to follow, comment and share. We need your help to enhance our visibility, so that our platform continues to serve you.

Surgical Considerations for a Patient on Semaglutide and Increased Risk for Aspiration Semaglutide (aka Ozepmic), a medication widely recognized for its efficacy in the treatment of type 2 diabetes and obesity, has been a game-changer for many. However, its impact on gastric motility—specifically, the delay in gastric emptying—presents a unique challenge for surgical safety, especially in the prevention of aspiration. This alteration in gastric physiology necessitates a tailored approach to preoperative assessment and management, emphasizing the need for vigilance and adaptation. Why does this matter? Delayed gastric emptying increases the risk of aspiration during anesthesia, a complication with potentially severe consequences. The standard fasting guidelines, although effective for the general population, may not suffice for patients on Semaglutide. Thus, a deeper dive into each patient's medication regime, alongside their individual response to treatment, becomes essential. A Call to Action for Enhanced Collaboration Addressing this concern requires a multidisciplinary effort, bridging the expertise of anesthesiologists, endocrinologists, and surgeons. Preoperative evaluation should include a thorough review of the patient's medication schedule, with particular attention to the timing of Semaglutide administration. Adjusting the preoperative fasting period and considering the use of prokinetic agents may be necessary to minimize aspiration risk. Moreover, engaging in patient education about the importance of disclosing all medications during the preoperative visit cannot be overstated. As we continue to learn more about the complexities of administering anesthesia to patients on Semaglutide, I want to underscore the importance of personalized care plans. By acknowledging the unique challenges posed by delayed gastric emptying, we can ensure not only the safety of our patients but also the efficacy of surgical interventions. Together, through informed decision-making and collaborative practice, we can continue to advance patient care in an era of evolving medical treatments. https://lnkd.in/gBW4qyDZ If you have a patient that has suffered aspiration due to Semaglutide use, click the link below to learn how I can help your organization with analyzing the patient's medical history! www.aecconsultingllc.com #AECConsultingLLC #LegalNurseConsultant #NurseExpertWitness #MedicalMalpractice #PatientSafety

Program Updates from AdventHealth Gastroenterology & Hepatology! We're thrilled to share our 2021-2023 Program Update, showcasing our achievements, expansions, and future endeavors. Despite the challenges posed by the global pandemic, our team has shown remarkable resilience and growth. ✨ Expanded our General GI program, establishing one of Florida's largest and most specialized centers. ✨ Launched new initiatives like the Pancreas Center, Third Space Endoscopy, and the Endoscopic Weight Loss Program. ✨ Initiated our GI Fellowship Program in 2022 and expanded our Interventional Endoscopy Fellowship Program, recognized nationally. ✨ Opened a second Center for Interventional Endoscopy in Celebration to make expert care more accessible. ✨ Committed to groundbreaking research, with active clinical trials offering innovative treatment options to our patients. Looking forward, we are excited about our plans for 2024, including new locations, team expansions, and continued dedication to clinical excellence and patient-focused care. Check out our full program update for more details on our progress and future. Together, we're shaping the future of gastroenterology and hepatology care! #HealthcareExcellence #Gastroenterology #Hepatology #AdventHealth #ClinicalResearch #PatientCare #MedicalEducation

A recent study presented at Canadian Digestive Disease Week 2023 examined patients who underwent gastrointestinal endoscopy (GIE) while admitted to ward-level care at Toronto General Hospital. The study found that patients with comorbidities affecting major organ systems or a recent history of mechanical ventilation or previous critical care involvement were more likely to require critical care again after endoscopy. Most patients needing critical care post-GIE had complications unrelated to the endoscopy itself. The study highlights the importance of carefully assessing high-risk patients and considering anesthesia consultation and support during endoscopic procedures. For more details - https://mat.cyou/HrtIq #endoscopytech #endoscopyit #endoscopyimaing #AI #informationtecgnology #healthcare

After the COVID-19 pandemic, multiple reviews have documented the success of veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Patients who experience hypoxemia but have normal contractility may be switched to veno-venous-ECMO (VV-ECMO). #Anesthesia #Avalon #ECMO

The use of #sodium-glucose cotransporter 2 inhibitors (#SGLT2i) has increased rapidly for patients with #diabetes , #heartfailure, and #chronickidneydisease. However, these medications can cause #euglycemic diabetic ketoacidosis (eDKA) in the perioperative period. The #fda (Food and Drug Administration) has updated their recommendations that they be held for at least 3-to-4 days preoperatively. But what about patients presenting for emergency surgery or elective surgery without holding the medications per #fda guidelines? At the #University of #Pennsylvania, a multidisciplinary team has developed comprehensive guidelines for managing patients taking #SGLT2i during the #perioperative period. The guidelines cover preoperative, intraoperative, and postoperative management and were developed by the Departments of #Anesthesiology, #Endocrinology, and #Pharmacy. In their recent article, the authors present these guidelines and discuss challenges encountered while implementing them at a large #academic #medical center with satellite hospitals and surgery centers with varying resources and patient populations. These guidelines will help ensure the safe management of patients taking SGLT2i during surgery. #SGLT2i #perioperativemanagement #patientcare #UniversityofPennsylvania #medicalguidelines #diabetes